Research Papers

25 of 519 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefit…
Yoon JH; Choi W; Park JY; Hong AR; Kim HK; Kang HC.
Endocrinol Metab (Seoul) (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
FoxO6-Mediated TXNIP Induces Lipid Accumulation in the Liver through NLRP3 Inflammasome Activation.
Kim ME; Lee JS; Kim TW; Park MH; Kim DH.
Endocrinol Metab (Seoul) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Hypothalamic AMP-Activated Protein Kinase as a Whole-Body Energy Sensor and Regulator.
Min SH; Song DK; Lee CH; Roh E; Kim MS.
Endocrinol Metab (Seoul) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines.
Kim MJ; Moon JH; Lee EK; Song YS; Jung KY; Lee JY; Kim JH; Kim K; Park SK; Park YJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency.
Charoensri S; Auchus RJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2024
2/6 Transparent
The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin.
Nijenhuis-Noort EC; Berk KA; Neggers SJCMM; Lely AJV.
Endocrinol Metab (Seoul) (Unknown)
Published: 2024
2/6 Transparent
Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AK…
Lee J; Hong SW; Kim MJ; Lim YM; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY.
Endocrinol Metab (Seoul) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Acromegaly and Bone: An Update.
Giustina A.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Initial Combination Therapy in Type 2 Diabetes.
Kim JY; Kim NH.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Phospholipase C-γ as a Potential Therapeutic Target for Graves' Orbitopathy.
Roh TH; Chae MK; Ko JS; Kikkawa DO; Jang SY; Yoon JS.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.
Whyte E; Nezu M; Chik C; Tateno T.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Exploring the Association between Thyroid Function and Frailty: Insights from Representative Korean Data.
Lee YJ; Kim MH; Lim DJ; Lee JM; Chang SA; Lee J.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
AM1638, a GPR40-Full Agonist, Inhibited Palmitate- Induced ROS Production and Endoplasmic Reticulum Stress, Enhancing H…
Hwang HJ; Kim JW; Yun S; Park MJ; Song E; Jang S; Jang A; Choi KM; Baik SH; Yoo HJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Increased Risk of Hip Fracture in Patients with Acromegaly: A Nationwide Cohort Study in Korea.
Kim J; Hong N; Choi J; Moon JH; Kim EH; Lee EJ; Kim SG; Ku CR.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults.
Ji S; Kim K; Park SJ; Lee JY; Jung HW; Yoo HJ; Jang IY; Lee E; Baek JY; Kim BJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine.
Kim K; Ku CR; Lee EJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism.
Ha J; Park JH; Kim KJ; Kim JH; Jung KY; Lee J; Choi JH; Lee SH; Hong N; Lim JS; Park BK; Kim JH; Jung KC; Cho J; Kim MK; Chung CH; Committee of Clinical Practice Guideline of Korean Endocrine Society; Korean Adrenal Study Group of Korean Endocrine Society.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
The Benefits Of Continuous Glucose Monitoring In Pregnancy.
Yoo JH; Kim JH.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Characteristics Associated with Bone Loss after Spinal Cord Injury: Implications for Hip Region Vulnerability.
Han S; Shin S; Kim O; Hong N.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Emerging Importance of Mitochondria in White Adipocytes: Neither Last nor Least.
Cai J; Wang F; Shao M.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Risk of Cause-Specific Mortality across Glucose Spectrum in Elderly People: A Nationwide Population-Based Cohort Study.
Lee J; Kim HS; Song KH; Yoo SJ; Han K; Lee SH; Committee of Big Data; Korean Endocrine Society.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Age-Dependent Association of Height Loss with Incident Fracture Risk in Postmenopausal Korean Women.
Lee C; Park HS; Rhee Y; Hong N.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Beyond Acute COVID-19: Investigating the Incidence of Subacute Thyroiditis in Long COVID-19 in Korea.
Lee J; Seo GH; Song K.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guide…
Ku EJ; Yoo WS; Chung HK.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Phloretin Ameliorates Succinate-Induced Liver Fibrosis by Regulating Hepatic Stellate Cells.
Le CT; Nguyen G; Park SY; Dong HN; Cho YK; Lee JH; Im SS; Choi DH; Cho EH.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared